0001562180-18-004456.txt : 20181107 0001562180-18-004456.hdr.sgml : 20181107 20181107181859 ACCESSION NUMBER: 0001562180-18-004456 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181105 FILED AS OF DATE: 20181107 DATE AS OF CHANGE: 20181107 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Orticerio Ernest CENTRAL INDEX KEY: 0001724369 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38319 FILM NUMBER: 181167711 MAIL ADDRESS: STREET 1: C/O QUANTERIX CORPORATION STREET 2: 113 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Quanterix Corp CENTRAL INDEX KEY: 0001503274 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 208957988 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 113 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617-301-9400 MAIL ADDRESS: STREET 1: 113 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2018-11-05 false 0001503274 Quanterix Corp QTRX 0001724369 Orticerio Ernest C/O QUANTERIX CORPORATION, 113 HARTWELL AVENUE LEXINGTON MA 02421 false true false false SVP Finance and Corporate Dev Common Stock 2018-11-05 4 M false 10000.00 2.28 A 63802.00 D Common Stock 2018-11-05 4 S false 10000.00 17.124 D 53802.00 D Common Stock 2018-11-07 4 M false 1171.00 2.28 A 54973.00 D Common Stock 2018-11-07 4 S false 1171.00 16.50 D 53802.00 D Common Stock 2018-11-07 4 M false 8829.00 2.28 A 62631.00 D Common Stock 2018-11-07 4 S false 8829.00 16.5261 D 53802.00 D Stock Option (Right to Buy) 2.28 2018-11-05 4 M false 10000.00 0.00 D 2022-02-03 Common Stock 10000.00 11670.00 D Stock Option (Right to Buy) 2.28 2018-11-07 4 M false 8829.00 0.00 D 2022-02-03 Common Stock 8829.00 2841.00 D Stock Option (Right to Buy) 2.28 2018-11-07 4 M false 1171.00 0.00 D 2022-02-03 Common Stock 1171.00 1670.00 D Includes 7,131 restricted stock units that vest as to 25% of the shares on May 10, 2019 and as to an additional 2.083% of the shares per month for 36 months thereafter. This transaction was executed in multiple trades at prices ranging from $17.10 to $17.21. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $16.50 to $16.69. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. All shares underlying the option have vested. /s/ Brian Keane, as Attorney-in-Fact 2018-11-07